Your session is about to expire
← Back to Search
Augmented Reality Rehabilitation for Stroke-Related Neglect
N/A
Recruiting
Led By Murat Akcakaya, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
acute stroke
intact auditory function (positive test on Auditory Sensation Test)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4
Awards & highlights
Study Summary
This trial is testing a new tool to help people with neglect, a condition where they don't pay attention to one side of their body. The tool uses augmented reality and EEG to help detect and rehabilitate neglect.
Who is the study for?
This trial is for adults over 18 who've had a stroke and are in inpatient rehab. They must have trouble noticing things on one side (neglect), be able to hear well, respond to vibrations, speak English, and miss targets in an AR test. People with dementia, Parkinson's disease, MS, brain tumors or metal implants that affect EEGs can't join.Check my eligibility
What is being tested?
The study is testing a new tool that uses augmented reality (AR) and brainwave monitoring (EEG) to find out if someone has neglect after a stroke and help them recover. Participants will use this AR system as part of their rehabilitation therapy.See study design
What are the potential side effects?
Since the intervention involves non-invasive AR and EEG technology for assessment and rehabilitation purposes rather than medication or surgery, significant side effects are not expected. However, some participants may experience discomfort from wearing the EEG cap or fatigue from the tasks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had a recent stroke.
Select...
My hearing is normal according to a hearing test.
Select...
I am 18 years old or older.
Select...
I am currently in a rehabilitation program as an inpatient.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accuracy; indicated by percent agreement between participant report and EEG-based assessment of neglect
Reliability; indicated by correlation coefficient between two consecutive sessions of EEG recording
Secondary outcome measures
Program Satisfaction; indicated by mean score of 3 or greater on the Client Satisfaction Questionnaire
Technology Satisfaction; indicated by a mean score of 3 or higher on the Quebec User Evaluation of Satisfaction with Assistive Technology
Trial Design
1Treatment groups
Experimental Treatment
Group I: augmented realityExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,926 Total Patients Enrolled
26 Trials studying Stroke
2,694 Patients Enrolled for Stroke
Northeastern UniversityOTHER
88 Previous Clinical Trials
61,300 Total Patients Enrolled
4 Trials studying Stroke
536 Patients Enrolled for Stroke
NSFUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a recent stroke.I have been diagnosed with dementia, Parkinson's, multiple sclerosis, or have a brain tumor.My hearing is normal according to a hearing test.I am 18 years old or older.I struggle to follow simple instructions most of the time.I am currently in a rehabilitation program as an inpatient.You have trouble accurately hitting targets on the Augmented Reality Screening Test more than 10% of the time.You have metal in your head that could disrupt the EEG system.
Research Study Groups:
This trial has the following groups:- Group 1: augmented reality
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open recruitment slots for this medical research?
"Per the data hosted on clinicaltrials.gov, this particular research endeavour is not presently enrolling individuals; it was initially posted February 1st 2023 and most recently revised October 31st 2022. Nevertheless, 1044 other medical trials are currently recruiting patients to partake in their studies."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger